Metabolic Signatures of Extreme Longevity in Northern Italian Centenarians Reveal a Complex Remodeling of Lipids, Amino Acids, and Gut Microbiota Metabolism

Abstract

The aging phenotype in humans has been thoroughly studied but a detailed metabolic profiling capable of shading light on the underpinning biological processes of longevity is still missing. Here using a combined metabonomics approach compromising holistic (1)H-NMR profiling and targeted MS approaches, we report for the first time the metabolic phenotype of longevity in a well characterized human aging cohort compromising mostly female centenarians, elderly, and young individuals. With increasing age, targeted MS profiling of blood serum displayed a marked decrease in tryptophan concentration, while an unique alteration of specific glycerophospholipids and sphingolipids are seen in the longevity phenotype. We hypothesized that the overall lipidome changes specific to longevity putatively reflect centenarians' unique capacity to adapt/respond to the accumulating oxidative and chronic inflammatory conditions characteristic of their extreme aging phenotype. Our data in centenarians support promotion of cellular detoxification mechanisms through specific modulation of the arachidonic acid metabolic cascade as we underpinned increased concentration of 8,9-EpETrE, suggesting enhanced cytochrome P450 (CYP) enzyme activity. Such effective mechanism might result in the activation of an anti-oxidative response, as displayed by decreased circulating levels of 9-HODE and 9-oxoODE, markers of lipid peroxidation and oxidative products of linoleic acid. Lastly, we also revealed that the longevity process deeply affects the structure and composition of the human gut microbiota as shown by the increased extrection of phenylacetylglutamine (PAG) and p-cresol sulfate (PCS) in urine of centenarians. Together, our novel approach in this representative Italian longevity cohort support the hypothesis that a complex remodeling of lipid, amino acid metabolism, and of gut microbiota functionality are key regulatory processes marking exceptional longevity in humans.

References 61

1. 1.

   Weinert BT, Timiras PS (2003 ) Invited review: Theories of aging. J Appl Physiol 95: 1706–1716.

   Not in our library10.1152/japplphysiol.00288.2003

2. 2.

   De BG, Carotenuto L, Carrieri G, De LM, Falcone E, et al (1998 ) Gene/longevity association studies at four autosomal loci (REN, THO, PARP, SOD2). Eur J Hum Genet 6: 534–541.

   Not in our library10.1038/sj.ejhg.5200222

3. 3.

   Radak Z, Zhao Z, Goto S, Koltai E (2011 ) Age-associated neurodegeneration andoxidative damage to lipids, proteins and DNA. Mol Aspects Med 32: 305–315.

   Not in our library10.1016/j.mam.2011.10.010

4. 4.

   Xue H, Xian B, Dong D, Xia K, Zhu S, et al (2007 ) A modular network model of aging. Mol Syst Biol 3: 147.

   Not in our library10.1038/msb4100189

5. 5.

   Sansoni P, Vescovini R, Fagnoni F, Biasini C, Zanni F, et al (2008 ) The immune system in extreme longevity. Exp Gerontol 43: 61–65.

   Not in our library10.1016/j.exger.2007.06.008

6. 6.

   Franceschi C (2007 ) Inflammaging as a major characteristic of old people: can it be prevented or cured? Nutr Rev 65: S173–S176.

   Not in our library10.1111/j.1753-4887.2007.tb00358.x

7. 7.
   Pathophysiology of ageing, longevity and age related diseases · 2007

   Not checked
8. 8.

   Li M, Wang B, Zhang M, Rantalainen M, Wang S, et al (2008 ) Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A 105: 2117–2122.

   Not in our library10.1073/pnas.0712038105

9. 9.

   Wijeyesekera A, Selman C, Barton RH, Holmes E, Nicholson JK, et al (2012 ) Metabotyping of Long-Lived Mice using (1)H NMR Spectroscopy. J Proteome Res 11: 2224–2235.

   Not in our library10.1021/pr2010154

10. 10.

    Wang Y, Lawler D, Larson B, Ramadan Z, Kochhar S, et al (2007 ) Metabonomic Investigations of Aging and Caloric Restriction in a Life-Long Dog Study. J Proteome Res 6: 1846–1854.

    Not in our library10.1021/pr060685n

11. 11.

    Rezzi S, Martin FP, Shanmuganayagam D, Colman RJ, Nicholson JK, et al (2009 ) Metabolic shifts due to long-term caloric restriction revealed in nonhuman primates. Exp Gerontol 44: 356–362.

    Not in our library10.1016/j.exger.2009.02.008

12. 12.

    Passarino G, Calignano C, Vallone A, Franceschi C, Jeune B, et al (2002 ) Male/female ratio in centenarians: a possible role played by population genetic structure. Exp Gerontol 37: 1283–1289.

    Not in our library10.1016/s0531-5565(02)00140-7

13. 13.

    Cevenini E, Invidia L, Lescai F, Salvioli S, Tieri P, et al (2008 ) Human models of aging and longevity. Expert Opin Biol Ther 8: 1393–1405.

    Not in our library10.1517/14712598.8.9.1393

14. 14.

    Atzmon G, Rincon M, Rabizadeh P, Barzilai N (2005 ) Biological evidence for inheritance of exceptional longevity. Mech Ageing Dev 126: 341–345.

    Not in our library10.1016/j.mad.2004.08.026

15. 15.

    Patterson D, Cabelof DC (2011 ) Down syndrome as a model of DNA polymerase beta haploinsufficiency and accelerated aging. Mech Ageing Dev

    Not in our library10.1016/j.mad.2011.10.001

16. 16.
    Through Ageing, and Beyond: Gut Microbiota and Inflammatory Status in Seniors and Centenarians · 2010

    Corrected
17. 17.

    Baur P, Martin FP, Gruber L, Bosco N, Brahmbhatt V, et al (2011 ) Metabolic Phenotyping of the Crohn's Disease-like IBD Etiopathology in the TNF(DeltaARE/WT) Mouse Model. J Proteome Res

    Not in our library10.1021/pr2007973

18. 18.

    Deems R, Buczynski MW, Bowers-Gentry R, Harkewicz R, Dennis EA (2007 ) Detection and quantitation of eicosanoids via high performance liquid chromatography electrospray ionization-mass spectrometry. Methods Enzymol 432: 59–82.

    Not in our library10.1016/s0076-6879(07)32003-x

19. 19.

    Cloarec O, Dumas ME, Craig A, Barton RH, Trygg J, et al (2005 ) Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. Anal Chem 77: 1282–1289.

    Not in our library10.1021/ac048630x

20. 20.

    Liaw A, Wiener M (2002 ) Classification and regression by randomForest. R News 3: 18–22.

    Not in our library

21. 21.

    Magni E, Binetti G, Bianchetti A, Rozzini R, Trabucchi M (1996 ) Mini-Mental State Examination: a normative study in Italian elderly population. Eur J Neurol 3: 198–202.

    Not in our library10.1111/j.1468-1331.1996.tb00423.x

22. 22.

    Byrne GI, Lehmann LK, Kirschbaum JG, Borden EC, Lee CM, et al (1986 ) Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity. J Interferon Res 6: 389–396.

    Not in our library10.1089/jir.1986.6.389

23. 23.

    Gupta NK, Thaker AI, Kanuri N, Riehl TE, Rowley CW, et al (2011 ) Serum analysis of tryptophan catabolism pathway: Correlation with Crohn's disease activity. Inflamm Bowel Dis

    Not in our library10.1002/ibd.21849

24. 24.
    Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer · 2002

    No notice
25. 25.

    Aiyar N, Disa J, Ao Z, Ju H, Nerurkar S, et al (2007 ) Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells. Mol Cell Biochem 295: 113–120.

    Not in our library10.1007/s11010-006-9280-x

26. 26.

    Schmitz G, Ruebsaamen K (2010 ) Metabolism and atherogenic disease association of lysophosphatidylcholine. Atherosclerosis 208: 10–18.

    Not in our library10.1016/j.atherosclerosis.2009.05.029

27. 27.

    Fuchs B, Schiller J, Wagner U, Hantzschel H, Arnold K (2005 ) The phosphatidylcholine/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: investigations by 31P NMR and MALDI-TOF MS. Clin Biochem 38: 925–933.

    Not in our library10.1016/j.clinbiochem.2005.06.006

28. 28.

    Wijeyesekera A, Selman C, Barton RH, Holmes E, Nicholson JK, et al (2012 ) Metabotyping of long-lived mice using 1H NMR spectroscopy. J Proteome Res 11: 2224–2235.

    Not in our library10.1021/pr2010154

29. 29.

    Perls TT, Wilmoth J, Levenson R, Drinkwater M, Cohen M, et al (2002 ) Life-long sustained mortality advantage of siblings of centenarians. Proc Natl Acad Sci U S A 99: 8442–8447.

    Not in our library10.1073/pnas.122587599

30. 30.

    Suliman ME, Qureshi AR, Stenvinkel P, Pecoits-Filho R, Barany P, et al (2005 ) Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease. Am J Clin Nutr 82: 342–349.

    Not in our library10.1093/ajcn.82.2.342

31. 31.

    Dillon EL, Sheffield-Moore M, Paddon-Jones D, Gilkison C, Sanford AP, et al (2009 ) Amino acid supplementation increases lean body mass, basal muscle protein synthesis, and insulin-like growth factor-I expression in older women. J Clin Endocrinol Metab 94: 1630–1637.

    Not in our library10.1210/jc.2008-1564

32. 32.

    Kummerow FA, Cook LS, Wasowicz E, Jelen H (2001 ) Changes in the phospholipid composition of the arterial cell can result in severe atherosclerotic lesions. J Nutr Biochem 12: 602–607.

    Not in our library10.1016/s0955-2863(01)00181-4

33. 33.

    Yeboah J, McNamara C, Jiang XC, Tabas I, Herrington DM, et al (2010 ) Association of plasma sphingomyelin levels and incident coronary heart disease events in an adult population: Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol 30: 628–633.

    Not in our library10.1161/atvbaha.109.199281

34. 34.

    Nagan N, Zoeller RA (2001 ) Plasmalogens: biosynthesis and functions. Prog Lipid Res 40: 199–229.

    Not in our library10.1016/s0163-7827(01)00003-0

35. 35.

    Pereira SP, Cassell TB, Engelman JL, Sladen GE, Murphy GM, et al (1996 ) Plasma arachidonic acid-rich phospholipids in Crohn's disease: response to treatment. Clin Sci (Lond) 91: 509–512.

    Not in our library10.1042/cs0910509

36. 36.

    Hsieh CC, Papaconstantinou J (2004 ) Akt/PKB and p38 MAPK signaling, translational initiation and longevity in Snell dwarf mouse livers. Mech Ageing Dev 125: 785–798.

    Not in our library10.1016/j.mad.2004.07.008

37. 37.

    Laplante M, Sabatini DM (2009 ) An emerging role of mTOR in lipid biosynthesis. Curr Biol 19: R1046–R1052.

    Not in our library10.1016/j.cub.2009.09.058

38. 38.

    Schieke SM, Finkel T (2007 ) TOR and aging: less is more. Cell Metab 5: 233–235.

    Not in our library10.1016/j.cmet.2007.03.005

39. 39.

    Sharp ZD, Strong R (2010 ) The role of mTOR signaling in controlling mammalian life span: what a fungicide teaches us about longevity. J Gerontol A Biol Sci Med Sci 65: 580–589.

    Not in our library10.1093/gerona/glp212

40. 40.

    Maeba R, Maeda T, Kinoshita M, Takao K, Takenaka H, et al (2007 ) Plasmalogens in human serum positively correlate with high- density lipoprotein and decrease with aging. J Atheroscler Thromb 14: 12–18.

    Not in our library10.5551/jat.14.12

41. 41.

    Radmark O (2003 ) 5-lipoxygenase-derived leukotrienes: mediators also of atherosclerotic inflammation. Arterioscler Thromb Vasc Biol 23: 1140–1142.

    Not in our library10.1161/01.atv.0000082460.58448.01

42. 42.

    Takata S, Papayianni A, Matsubara M, Jimenez W, Pronovost PH, et al (1994 ) 15-Hydroxyeicosatetraenoic acid inhibits neutrophil migration across cytokine-activated endothelium. Am J Pathol 145: 541–549.

    Not in our library

43. 43.

    Seubert JM, Zeldin DC, Nithipatikom K, Gross GJ (2007 ) Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury. Prostaglandins Other Lipid Mediat 82: 50–59.

    Not in our library10.1016/j.prostaglandins.2006.05.017

44. 44.

    Campbell WB (2000 ) New role for epoxyeicosatrienoic acids as anti-inflammatory mediators. Trends Pharmacol Sci 21: 125–127.

    Not in our library10.1016/s0165-6147(00)01472-3

45. 45.

    Jira W, Spiteller G, Richter A (1997 ) Increased levels of lipid oxidation products in low density lipoproteins of patients suffering from rheumatoid arthritis. Chem Phys Lipids 87: 81–89.

    Not in our library10.1016/s0009-3084(97)00030-3

46. 46.

    Gaskins AJ, Rovner AJ, Mumford SL, Yeung E, Browne RW, et al (2010 ) Adherence to a Mediterranean diet and plasma concentrations of lipid peroxidation in premenopausal women. Am J Clin Nutr 92: 1461–1467.

    Not in our library10.3945/ajcn.110.000026

47. 47.

    Jira W, Spiteller G, Richter A (1997 ) Increased levels of lipid oxidation products in low density lipoproteins of patients suffering from rheumatoid arthritis. Chem Phys Lipids 87: 81–89.

    Not in our library10.1016/s0009-3084(97)00030-3

48. 48.

    Jira W, Spiteller G, Carson W, Schramm A (1998 ) Strong increase in hydroxy fatty acids derived from linoleic acid in human low density lipoproteins of atherosclerotic patients. Chem Phys Lipids 91: 1–11.

    Not in our library10.1016/s0009-3084(97)00095-9

49. 49.

    Davinelli S, Willcox DC, Scapagnini G (2012 ) Extending healthy ageing: nutrient sensitive pathway and centenarian population. Immun Ageing 9: 9.

    Not in our library10.1186/1742-4933-9-9

50. 50.

    Calder PC (2008 ) Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res 52: 885–897.

    Not in our library10.1002/mnfr.200700289

51. 51.

    Guigoz Y, Dore J, Schiffrin EJ (2008 ) The inflammatory status of old age can be nurtured from the intestinal environment. Curr Opin Clin Nutr Metab Care 11: 13–20.

    Not in our library10.1097/mco.0b013e3282f2bfdf

52. 52.

    Claesson MJ, Cusack S, O'Sullivan O, Greene-Diniz R, de WH, et al (2011 ) Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A 108 Suppl 1: 4586–4591.

    Not in our library10.1073/pnas.1000097107

53. 53.

    Clayton TA, Baker D, Lindon JC, Everett JR, Nicholson JK (2009 ) Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci U S A 106: 14728–14733.

    Not in our library10.1073/pnas.0904489106

54. 54.

    Smith EA, Macfarlane GT (1997 ) Formation of Phenolic and Indolic Compounds by Anaerobic Bacteria in the Human Large Intestine. Microb Ecol 33: 180–188.

    Not in our library10.1007/s002489900020

55. 55.

    Xu XM, Sansores-Garcia L, Chen XM, Matijevic-Aleksic N, Du M, et al (1999 ) Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. Proc Natl Acad Sci U S A 96: 5292–5297.

    Not in our library10.1073/pnas.96.9.5292

56. 56.

    Elsden SR, Hilton MG, Waller JM (1976 ) The end products of the metabolism of aromatic amino acids by Clostridia. Arch Microbiol 107: 283–288.

    Not in our library10.1007/bf00425340

57. 57.

    Baumgart M, Dogan B, Rishniw M, Weitzman G, Bosworth B, et al (2007 ) Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J 1: 403–418.

    Not in our library10.1038/ismej.2007.52

58. 58.

    Peng L, He Z, Chen W, Holzman IR, Lin J (2007 ) Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr Res 61: 37–41.

    Not in our library10.1203/01.pdr.0000250014.92242.f3

59. 59.

    Oostendorp M, Engelke UF, Willemsen MA, Wevers RA (2006 ) Diagnosing inborn errors of lipid metabolism with proton nuclear magnetic resonance spectroscopy. Clin Chem 52: 1395–1405.

    Not in our library10.1373/clinchem.2006.069112

60. 60.

    Rezzi S, Ramadan Z, Martin FP, Fay LB, Van BP, et al (2007a ) Human metabolic phenotypes link directly to specific dietary preferences in healthy individuals. J Proteome Res 6: 4469–4477.

    Not in our library10.1021/pr070431h

61. 61.

    Siddiqui N, Sim J, Silwood CJ, Toms H, Iles RA, et al (2003 ) Multicomponent analysis of encapsulated marine oil supplements using high-resolution 1H and 13C NMR techniques. J Lipid Res 44: 2406–2427.

    Not in our library10.1194/jlr.d300017-jlr200

Cited by papers we hold 15

• The metabolomics of human aging: Advances, challenges, and opportunities · 2022
  No notice
• Microbiota-derived metabolites as drivers of gut–brain communication · 2022
  No notice
• Gut microbiota as the key controllers of “healthy” aging of elderly people · 2021
  No notice
• Shotgun Metagenomics of Gut Microbiota in Humans with up to Extreme Longevity and the Increasing Role of Xenobiotic Degradation · 2020
  No notice
• A Cross-Sectional Study of Compositional and Functional Profiles of Gut Microbiota in Sardinian Centenarians · 2019
  No notice
• Tryptophan Metabolism in Inflammaging: From Biomarker to Therapeutic Target · 2019
  No notice
• Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism · 2018
  No notice
• The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates · 2018
  No notice
• Biomarker signatures of aging · 2017
  No notice
• Gut microbiota changes in the extreme decades of human life: a focus on centenarians · 2017
  No notice
• Metabolite patterns predicting sex and age in participants of the Karlsruhe Metabolomics and Nutrition (KarMeN) study · 2017
  No notice
• Decreased epigenetic age of PBMCs from Italian semi-supercentenarians and their offspring · 2015
  No notice
• Towards microbial fermentation metabolites as markers for health benefits of prebiotics · 2015
  No notice
• Serum profiling of healthy aging identifies phospho- and sphingolipid species as markers of human longevity · 2014
  No notice
• Functional metagenomic profiling of intestinal microbiome in extreme ageing · 2013
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.